Fetching article feeds... #3 ... 0/10 #4 ... 0/10 #5 ... 0/10 #6 ... 0/10 #7 ... 0/10 #8 ... 20/20 #9 ... 20/20 #10 ... 20/20 #11 ... 18/20 #12 ... 2/20 #13 ... 20/20 #14 ... 8/20 #15 ... 19/20 #16 ... 20/20
Latest articles: FDA Accepts Filing and Grants Priority Review for DX-88 for ... - WELT ONLINE
FDA Accepts Filing and Grants Priority Review for DX-88 for ... WELT ONLINE, Germany - 3 hours ago (NASDAQ: DYAX) announced today that the US Food and Drug Administration (FDA) has accepted for filing the Company’s Biologics License Application (BLA) for ... UPDATE 1-Dyax's genetic disease drug granted fast review Reuters all 16 news FDA Accepts Filing and Grants Priority Review for DX-88 for ... - WELT ONLINE... 1st flu case of season diagnosed in Arizona It probably began with a whimper. 1st flu case of season diagnosed in Arizona... States disagree greatly on Amber Alert criteria ATLANTA - Authorities count hundreds of Amber Alert cases across the country as success stories when they start explaining why the media-friendly and politically popular bulletins are so important. States disagree greatly on Amber Alert criteria ... Nurses -- Utah needs tougher helmet, seat belt laws Utah is improving its road safety laws, but is still lacking a few key provisions, the Emergency Nurses Association said in a report released this week.
Nurses -- Utah needs tougher helmet, seat belt laws... FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder GlaxoSmithKline (NYSE:GSK) today announced that the United States Food and Drug Administration (FDA) granted accelerated approval for PROMACTA(R) (eltrombopag) for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder... Genetic Biobanks: Deposits, Withdrawals, and Consumer Protection Biobanks, and studies based on them, have swiftly proliferated in recent years. Genetic Biobanks: Deposits, Withdrawals, and Consumer Protection... Scientists are high on idea that marijuana reduces memory impairment The more research they do, the more evidence Ohio State University scientists find that specific elements of marijuana can be good for the aging brain by reducing inflammation there and possibly even stimulating the formation of new brain cells. Scientists are high on idea that marijuana reduces memory impairment... Cyberonics Reports Strong Sales Growth and Profitability in Fiscal ... - MarketWatch
International Business Times Cyberonics Reports Strong Sales Growth and Profitability in Fiscal ... MarketWatch - Nov 19, 2008 Net sales of $36.0 million, a 24% increase from $28.9 million, -- Net US product sales attributable to the epilepsy indication increased by an estimated 32% ... Cyberonics Swings To Q2 Profit On Top Line Cyberonics Reports Strong Sales Growth and Profitability in Fiscal ... - MarketWatch... Bionic Woman Lindsay Wagner makes a giant leap of faith - Yorkshire Post
Bionic Woman Lindsay Wagner makes a giant leap of faith Yorkshire Post, UK - Nov 19, 2008 Years later, in her mid- 30s, while visiting a school for children with dyslexia Lindsay recognised herself. "No-one really knew about dyslexia when I was ... Bionic Woman Lindsay Wagner makes a giant leap of faith - Yorkshire Post... Some abortion foes shifting focus from ban to reduction Frustrated by the failure to overturn Roe v. Wade, a growing number of antiabortion pastors, conservative academics and activists are setting aside efforts to outlaw abortion and instead are focusing on building social programs and developing other assistance for pregnant women to reduce the number of abortions. Some abortion foes shifting focus from ban to reduction... Articles 1..10 of 1597. | Next > |